focus -WSS

focus

author：fashion 2025-09-29 01:09:27 - browse：9

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for Duchenne muscular dystrophy. Regulators restricted the treatment to younger patients, with additional data required to broaden its use.

The gene therapy, called Elevydis, is made by Sarepta Therapeutics. The company will charge $3.2 million for the treatment, making it the U.S.’s second most expensive drug, behind a recently approved gene therapy for hemophilia. CEO Doug Ingram said on a conference call the price was below what a recently published company-funded analysis found would be cost-effective.

“The approval of Elevidys is a watershed moment for the treatment of Duchenne. Elevydis is the first and only gene therapy approved for Duchenne, and this approval brings us closer to our goal of bringing forward a treatment that provides the potential to alter the trajectory of this degenerative disease,” Ingram said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Medicare drug price negotiation hearing pits pharma v Biden admin

WSS

Readout Newsletter: BridgeBio, Akero, and human embryo models

Medical device trials still don't enroll enough women, study finds

Cigna wins case to block Amy Bricker's move to CVS

Curing rare childhood diseases will falter unless Congress steps up

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

hotspot

focus

Wikipedia

Medical records are filled with copy

The untold story of TV’s first prescription drug ad

Affirmative action in medical school literally saved lives

Medicare drug price negotiation continues, as pharma counteroffers

Trump demands the U.S. pay no more for drugs than other countries … again

5 takeaways from STAT's examination of Zynex Medical

Malaria cases in Florida and Texas: Here’s what you need to know

Microsoft's Peter Lee: Generative AI could help doctors be more human

Apple is now the first public company to be valued at $3 trillion

Lack of health data on LGBTQ+ people has serious consequences

focus

STAT Virtual Event: ASCO Recap, Live!

The untold story of TV’s first prescription drug ad

Medical device trials still don't enroll enough women, study finds

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Stem cell biologist probes earliest stages of human development

The system is set up to fail children with medical complexity

hotspot

explore

hotspot

explore